Axogen forecasts at least $290M 2026 revenue, adds $7M from BioCircuit while planning prostate market development in 202

Axogen Q3 2026 earnings: revenue jumped 26%, guidance rose to $290M, and BioCircuit adds NerveTape growth potential.